Canada’s Drug Agency has received a letter from The Honourable Mark Holland that outlines our time-limited work related to An Act respecting ...
Latest News
Canada’s Drug Agency is proud to welcome Maureen Smith as the first-ever Patient Member on our Board of Directors. Maureen is a respected leader in ...
A new coalition, announced today, unites 11 organizations that are working collectively to improve the appropriate prescribing and use of medications ...
Current consultation status: Open Consultation period: November 28 to January 28, 2025
Canada’s Drug Agency is launching a consultation on our first ...
Canada’s Drug Agency, with support from our health system partners including ICES and Health Data Research Network Canada (HDRN), has published a new ...
Canada’s Drug Agency is pleased to announce the successful applicants from our 2024 Request for Proposals (RFP) to support the enhancement of rare ...
Upcoming Events
All Upcoming Events12th Annual Data Analytics for Healthcare Summit
Webinar: Patient Organization Preconsultation — Enhancing the Drug Reimbursement Review Process
Health Economics: Demystifying the Myths and Unlocking Its Value
Symposium 2024
Symposium 2024 is a 3-day hybrid event that gathers leaders from across Canada with expertise in policy, industry, health technology assessment, patient advocacy, medicine, public health, and communications. The theme of Symposium 2024 is From Disruption to Opportunity: Embracing Change in Health Care.
